Covered recipient · General Payments record
PARVIN SHAFA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,633.59
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $374.78 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $143.03 | 9 |
| Galderma Laboratories, L.P. | $88.46 | 5 |
| PFIZER INC. | $70.44 | 1 |
| GENZYME CORPORATION | $24.01 | 1 |
| Incyte Corporation | $18.66 | 1 |
| LEO Pharma Inc. | $16.00 | 1 |
| Verrica Pharmaceuticals Inc. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $1.07 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680472 | CMS |
| Amgen Inc. | $20.48 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680474 | CMS |
| Amgen Inc. | $16.68 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680476 | CMS |
| Amgen Inc. | $27.36 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680478 | CMS |
| Amgen Inc. | $1.15 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680480 | CMS |
| Amgen Inc. | $1.44 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680482 | CMS |
| Amgen Inc. | $19.20 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680484 | CMS |
| Amgen Inc. | $32.16 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680486 | CMS |
| Amgen Inc. | $23.49 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117680488 | CMS |
| Galderma Laboratories, L.P. | $16.45 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145327366 | CMS |
| Galderma Laboratories, L.P. | $15.71 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145327368 | CMS |
| Galderma Laboratories, L.P. | $19.88 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145327370 | CMS |
| Galderma Laboratories, L.P. | $18.21 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145327372 | CMS |
| Galderma Laboratories, L.P. | $18.21 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145327374 | CMS |
| GENZYME CORPORATION | $24.01 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139778550 | CMS |
| Incyte Corporation | $18.66 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141264883 | CMS |
| LEO Pharma Inc. | $16.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152650663 | CMS |
| PFIZER INC. | $70.44 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132099015 | CMS |
| Verrica Pharmaceuticals Inc. | $14.18 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118386584 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.